x

Search for a clinical trial

* (*) mandatory field

Phase I Open Label, Dose Escalation, Monotherapy Trial of Afatinib to Determine the MTD, Safety, PK and Efficacy of Afatinib in Children Aged 2 Years to <18 Years With Recurrent/Refractory Neuroectodermal Tumours, Rhabdomyosarcoma and Tumours With ErbB Pathway Deregulation - AT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Boehringer ingelheim
  • Website
  • Principal investigator of clinical trial

  • Pr Ruth LADENSTEIN
  • Zentrum fŘr Kinder- und Jugendheilkunde
  • St. Anna Kinderspital
  • Kinderspitalgasse 6
  • 1090 WIEN
  • AUSTRIA
  • More information
  • Phone  : +43 (0)1 40170
  • Fax  : -
  • Website
  • Sponsor of clinical trial

  • BOEHRINGER INGELHEIM
  • Boehringer Ingelheim
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Binger Stra▀e 173
  • 55216 INGELHEIM AM RHEIN
  • GERMANY
  • More information
  • Phone  : 49 (0)6132 77 0
  • Fax  : 49 (0)6132 72 0
  • Website
Last update: September 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.